Northern Cancer Alliance to benefit from new deal with Sectra
The solution will span ten separate trusts that form part of the Northern Cancer Alliance, aiming to improve cancer care workflows.
Special Report: Diagnostic Digital Pathology
Both NHS staff and vendors say the interest in diagnostic digital pathology is growing. So could this previously larger analogue specialty be about to fully take the digital plunge? Jennifer Trueland investigates.
Advisory Series: Interoperability
Data sharing between primary and secondary care has long been a digital challenge for the NHS. But with Matt Hancock focusing his attention on resolving the problem and a new national programme underway, is a corner about to be turned? Maja Dragovic finds out.
Special Report: VNA and Data Storage
The benefits of vendor neutral archives in healthcare have been well rehearsed. But could combining this kind of storage with the growth of cloud yield even more advantages for the NHS? Maja Dragovic investigates.
Special Report: Cloud
Earlier this year, national bodies officially approved the use of cloud for NHS data. But does this mean NHS organisations are now embracing it wholesale? Vivienne Raper investigates.
Digital pathology: Do we need to take the lab out of the hospital?
As Lord Carter’s pathology recommendations near a decade old, is it time to take the laboratory out of the hospital? Jane Rendall, managing director of Sectra UK and Ireland, asks the question.
Industry news in brief
Industry nibs include nominated trusts in the running for best global digital exemplar, major contract deals and what NHS trusts spend per day on PCs.
Two North West trusts aiming to connect diagnostics across hospitals
Two North West trusts have acquired Sectra’s PACS and VNA, with a view to more easily sharing diagnostic data between their organisations.
Clinical Software 1
Salford urges move to digital pathology
Salford Royal NHS Foundation Trust has called for the whole of Manchester to use digital pathology services, following a successful pilot with Sectra.
Made to measure
Dose monitoring should deliver many benefits, but it’s proving hard to sell to NHS trusts. Kim Thomas reports ahead of the annual meeting of the UK Imaging Informatics Group this autumn.